Maurizio Maddestra
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study.
Journal: Frontiers in neurology
Published: June 19, 2022
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study.
Journal: The journal of headache and pain
Published: January 27, 2022
Gender Differences in 3-Month Outcomes of Erenumab Treatment-Study on Efficacy and Safety of Treatment With Erenumab in Men.
Journal: Frontiers in neurology
Published: September 11, 2021
Association between response to triptans and response to erenumab: real-life data.
Journal: The journal of headache and pain
Published: October 24, 2020
Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region.
Journal: The journal of headache and pain
Published: July 19, 2020
Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy.
Journal: The journal of headache and pain
Published: February 18, 2020
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
Journal: BMC neurology
Published: March 18, 2015
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.
Journal: International journal of immunopathology and pharmacology
Published: July 10, 2014
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population.
Journal: BMC neurology
Published: May 30, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026